Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151746 · ClinicalTrials.gov registry record · Phase 4
Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion
A Phase 4 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03151746 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 20 participants.
The verdict
NCT03151746, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The study's objective is to determine the efficacy of preoperative gabapentin in relieving postoperative pain, reducing opioid use and improving quality of recovery in subjects undergoing urologic surgery. Investigators hypothesize that subjects receiving gabapentin will have lower pain scores, less opioid consumption and better quality of recovery as compared to subjects who are given a placebo.
Interventions
- DRUG Placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-01-14 |
| Est. Completion | 2021-12-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03151746
The ClinicalTrials.gov registry entry for NCT03151746 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03151746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03151746 about?
NCT03151746 is a clinical study titled "Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion". The study's objective is to determine the efficacy of preoperative gabapentin in relieving postoperative pain, reducing opioid use and improving quality of recovery in subjects undergoing urologic surgery. Investigators hypothesize that subjects receiving gabapentin will have lower pain scores, les...
What is the current status of trial NCT03151746?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2018-01-14. Estimated completion is 2021-12-02.
What interventions are being tested in trial NCT03151746?
The interventions under investigation include: Placebo (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT03151746?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.